8-K/A 1 f76057a1e8-ka.htm AMENDMENT TO FORM 8-K Raytel Medical Form 8-K/A
Table of Contents

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934

         
    October 1, 2001    
   
   
    (Date of Report; Date of Earliest Event Reported)    
         
    Raytel Medical Corporation    
   
   
    (Exact name of registrant as specified in its charter)    
         
    Delaware    
   
   
    (State or other jurisdiction of incorporation)    
         
000-27186       942787342
     
(Commission File Number)       (IRS Employer Identification No.)
         
2755 Campus Drive, San Mateo, California       94403
     
(address of principal executive offices)       (Zip Code)
         
    (650) 349-0800    
   
   
    (Registrant’s telephone number, including area code)    

 

ITEM 5. Other Events.
ITEM 7. Financial Statements and Exhibits.
SIGNATURES
EXHIBIT INDEX
EXHIBIT 99.1

Table of Contents

ITEM 5. Other Events.

     Raytel Medical Corporation (Nasdaq: RTEL) (the “Company”) hereby incorporates by reference a press release from the Company dated October 1, 2001, which is filed herein as Exhibit 99.1.

ITEM 7. Financial Statements and Exhibits.

     (a)  Financial statements of business acquired:
     
       Not applicable.

     (b)  Pro forma financial information:
     
       Not applicable.

     (c)  Exhibits:

     
Exhibit No.   Description
 
99.1   Press Release dated October 1, 2001.

-2-

Table of Contents

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
     
  RAYTEL MEDICAL CORPORATION
 
 
Date: October 1, 2001 By:  /s/ John F. Lawler, Jr.
 
  John F. Lawler, Jr.
Vice President and Chief Financial Officer

-3-

Table of Contents

EXHIBIT INDEX

     
EXHIBIT NO.   DESCRIPTION
 
99.1   Press Release dated October 1, 2001

-4-